Business

July 14, 2014 11:56 AM

Salix gets good news from FDA on Relistor drug application

Salix Pharmaceuticals announced Monday that federal regulators have signaled they will approve its drug Relistor for treatment of chronic pain in non-cancer patients.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs